1Vercellini P, Viganb P, Somigliana E, et al. Adenomyosis:epidemiological factors[J]. Best Pract Res Clin ObstetGynaecol, 2006,20(4):465-477. DOI: 10.1016/j.bpobgyn.2006.01.017.
2Hyams LL. Adenomyosis; its conservative surgical treatment(hysteroplasty) in young women[J]. N Y State J Med, 1952,52(22):2778-2784.
3Fujishita A, Masuzaki H, Khan KN, et al. Modified reductionsurgery for adenomyosis. A preliminary report of thetransverse H incision technique[J]. Gynecol Obstet Invest,2004,57(3):132-138. DOI: 10.1159/000075830.
4Nishida M, Takano K, Arai Y, et al. Conservative surgicalmanagement for diffuse uterine adenomyosis[J]. Fertil Steril,2010,94(2):715-719. DOI: 10.1016/j.fertnstert.2009.03.046.
5Osada H, Silber S, Kakinuma T, et al. Surgical procedure toconserve the uterus for future pregnancy in patients sufferingfrom massive adenomyosis[J]. Reprod Biomed Online, 2011,22(1):94-99. DOI: 10.1016/j.rbmo.2010.09.014.
6Wada S, Kudo M,Minakami H. Spontaneous uterine ruptureof a twin pregnancy after a laparoscopic adenomyomectomy: acase report[J]. J Minim Invasive Gynecol, 2006,13(2):166-168. DOI: 10.10l6/j.jmig.2005.12.002.
7Sheng J, Zhang WY, Zhang JP, et al. The LNG-IUS study onadenomyosis: a 3-year follow-up study on the efficacy and sideeffects of the use of levonorgestrel intrauterine system for thetreatment of dysmenorrhea associated with adenomyosis[J].Contraception, 2009,79(3):189-193. DOI: 10.1016/j.contrace-ption.2008. 11.004.
8Park DS, Kim ML, Song T, et al. Clinical experiences of thelevonorgestrel-releasing intrauterine system in patients withlarge symptomatic adenomyosis[J]. Taiwan J Obstet Gynecol,2015,54(4):412-415. DOI: 10.1016/j.tjog.2014.05.009.
9Grimbizis GF, Mikos T,Tarlatzis B. Uterus-sparing operativetreatment for adenomyosis[J]. Fertil Steril, 2014,101(2):472-487. DOI: 10.1016/j.fertnstert.2013.10.025.
4Matalliotakis IM, Katsikis IK, Panidis DK. Adenomyosis: what is the impact on fertility?[J]. Curr Opin Obstet Gynecol, 2005, 17(3):261-264.
5Dueholm M, Lundorf E, Hansen ES, et al. Magnetic resonance imaging and transvaginal ultrasonography for the diagnosis of adenomyosis[J]. Fertil Steril, 2001,76(3):588-594.
6Woodforde JM, Merskey H. Some relationships between subjec- tire measures of pain[J]. J Psyehosom Res, 1972, 16(3): 173-178.
7Loekhat FB, Emembolu JO, Konje JC. The efficaey, side-effects and continuation rates in women with symptomatic endmnetriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up[J]. Hum Reprod, 2005,20(3):789-793.
8Yaman C, Jesacher K, Polz W. Accuraey of three-dimensional transvaginal ultrasound in uterus volume measurements, comparison with two-dimensional ultrasound[J]. Ultrasound Med Biol, 2003,29(12): 1681 - 1684.
9Petta CA, Ferriani RA, Abrao MS, et al. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronie pelvic pain in women with endometriosis[J]. Hum Reprod, 2005,20(7): 1993-1998.
10Benagiano G, Brosens I, Carrara S. Adenomyosis: new knowledge is generating new treatment strategies[J]. Womens Health (Lond Engl), 2009,5(3):297-311.
